6.
Darby S, Cutter D, Boerma M, Constine L, Fajardo L, Kodama K
. Radiation-related heart disease: current knowledge and future prospects. Int J Radiat Oncol Biol Phys. 2010; 76(3):656-65.
PMC: 3910096.
DOI: 10.1016/j.ijrobp.2009.09.064.
View
7.
Roychoudhuri R, Robinson D, Putcha V, Cuzick J, Darby S, Moller H
. Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: a population-based study. BMC Cancer. 2007; 7:9.
PMC: 1784099.
DOI: 10.1186/1471-2407-7-9.
View
8.
Haussmann J, Corradini S, Nestle-Kraemling C, Bolke E, Njanang F, Tamaskovics B
. Recent advances in radiotherapy of breast cancer. Radiat Oncol. 2020; 15(1):71.
PMC: 7106718.
DOI: 10.1186/s13014-020-01501-x.
View
9.
Fastner G, Reitsamer R, Gaisberger C, Stana M, Sedlmayer F
. [Intraoperative partial breast irradiation with electrons (ELIOT) compared to conventionally fractionated whole-breast irradiation of early-stage invasive breast cancer after breast-conserving surgery: long-term data from a prospective randomised...]. Strahlenther Onkol. 2021; 197(11):1032-1036.
DOI: 10.1007/s00066-021-01848-4.
View
10.
Liu G, Dong Z, Huang B, Liu Y, Tang Y, Li Q
. Efficacy and safety of accelerated partial breast irradiation: a meta-analysis of published randomized studies. Oncotarget. 2017; 8(35):59581-59591.
PMC: 5601757.
DOI: 10.18632/oncotarget.19225.
View
11.
Fastner G, Gaisberger C, Kaiser J, Scherer P, Ciabattoni A, Petoukhova A
. ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy with electrons (IOERT) in breast cancer. Radiother Oncol. 2020; 149:150-157.
DOI: 10.1016/j.radonc.2020.04.059.
View
12.
Schafer R, Strnad V, Polgar C, Uter W, Hildebrandt G, Ott O
. Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial. Lancet Oncol. 2018; 19(6):834-844.
DOI: 10.1016/S1470-2045(18)30195-5.
View
13.
Guinot J, Gonzalez-Perez V, Meszaros N, Major T, Najjari-Jamal D, Gutierrez-Miguelez C
. Very accelerated partial breast irradiation Phase I-II multicenter trial (VAPBI): Feasibility and early results. Brachytherapy. 2020; 20(2):332-338.
DOI: 10.1016/j.brachy.2020.10.010.
View
14.
Hannoun-Levi J, Montagne L, Sumodhee S, Schiappa R, Boulahssass R, Gautier M
. APBI Versus Ultra-APBI in the Elderly With Low-Risk Breast Cancer: A Comparative Analysis of Oncological Outcome and Late Toxicity. Int J Radiat Oncol Biol Phys. 2021; 111(1):56-67.
DOI: 10.1016/j.ijrobp.2021.03.052.
View
15.
Guidolin K, Yaremko B, Lynn K, Gaede S, Kornecki A, Muscedere G
. Stereotactic image-guided neoadjuvant ablative single-dose radiation, then lumpectomy, for early breast cancer: the SIGNAL prospective single-arm trial of single-dose radiation therapy. Curr Oncol. 2019; 26(3):e334-e340.
PMC: 6588073.
DOI: 10.3747/co.26.4479.
View
16.
Li Y, Barry P
. Pre-operative partial breast irradiation: revolutionizing radiation treatment for women with early stage breast cancer. Ann Breast Surg. 2023; 6.
PMC: 9837822.
DOI: 10.21037/abs-20-133.
View
17.
de Wild S, de Munck L, Simons J, Verloop J, van Dalen T, Elkhuizen P
. De-escalation of radiotherapy after primary chemotherapy in cT1-2N1 breast cancer (RAPCHEM; BOOG 2010-03): 5-year follow-up results of a Dutch, prospective, registry study. Lancet Oncol. 2022; 23(9):1201-1210.
DOI: 10.1016/S1470-2045(22)00482-X.
View
18.
Boughey J, Suman V, Mittendorf E, Ahrendt G, Wilke L, Taback B
. Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance). Ann Surg. 2015; 261(3):547-52.
PMC: 4324533.
DOI: 10.1097/SLA.0000000000000551.
View
19.
Fayanju O, Ren Y, Suneja G, Thomas S, Greenup R, Plichta J
. Nodal Response to Neoadjuvant Chemotherapy Predicts Receipt of Radiation Therapy After Breast Cancer Diagnosis. Int J Radiat Oncol Biol Phys. 2019; 106(2):377-389.
PMC: 6957225.
DOI: 10.1016/j.ijrobp.2019.10.039.
View
20.
Daveau C, Stevens D, Brain E, Berges O, Villette S, Moisson P
. Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy?. Int J Radiat Oncol Biol Phys. 2010; 78(2):337-42.
DOI: 10.1016/j.ijrobp.2009.08.053.
View